Skip to content

Study · Not a test of the peptide alone · 2026

1 result

Comparison of agar-based and checkerboard methods to assess phage-antimicrobial synergy in Pseudomonas aeruginosa.

Yılmaz U, Ünlü M, Ünlü GV

Journal of microbiological methods25 Feb 2026Cited by 3 (Europe PMC)

PMID41759663 (opens in a new tab)DOI10.1016/j.mimet.2026.107441 (opens in a new tab)PepBankPUB-41759663
Publisher pagePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Murepavadin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Murepavadin.

  1. 01LabNot a test of Murepavadin aloneIn vitro (cells)Activity measurement

    In vitro, BAUNPA3 and murepavadin showed synergy against Pseudomonas aeruginosa.

    In plain wordsIn lab tests, the BAUNPA3 phage and murepavadin combination showed synergy against Pseudomonas aeruginosa.

    Peptide
    Murepavadin
    Outcome
    IncreasePhage-antimicrobial synergy
    Study

    Pseudomonas aeruginosan: not reported in source

    Clinical MDR isolates
    Outcome group
    Infection and antimicrobial activity · Infection

    Source sentences

    Summary
    while BAUNPA3 showed synergy with murepavadin and pexiganan.
    1 context sentence
    Summary · context
    Synergy was assessed using modified double-layer agar and checkerboard assays under simultaneous and sequential applications.

    In this study, Murepavadin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Murepavadin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    27 Oct 2026, 18:20 UTC

    Study results updated

  2. Version 1

    27 Oct 2026, 16:32 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.